Biohit Oyj Statistics

Total Valuation

Biohit Oyj has a market cap or net worth of EUR 34.77 million. The enterprise value is 30.47 million.

Market Cap	34.77M
Enterprise Value	30.47M

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Biohit Oyj has 15.18 million shares outstanding. The number of shares has increased by 0.51% in one year.

Current Share Class	n/a
Shares Outstanding	15.18M
Shares Change (YoY)	+0.51%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	19.41%
Owned by Institutions (%)	n/a
Float	7.11M

Valuation Ratios

The trailing PE ratio is 20.99 and the forward PE ratio is 14.77.

PE Ratio	20.99
Forward PE	14.77
PS Ratio	2.48
PB Ratio	3.22
P/TBV Ratio	3.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.58, with an EV/FCF ratio of -55.80.

EV / Earnings	18.45
EV / Sales	2.18
EV / EBITDA	14.58
EV / EBIT	17.66
EV / FCF	-55.80

Financial Position

The company has a current ratio of 4.30, with a Debt / Equity ratio of 0.06.

Current Ratio	4.30
Quick Ratio	3.97
Debt / Equity	0.06
Debt / EBITDA	0.34
Debt / FCF	-1.28
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 16.68% and return on invested capital (ROIC) is 10.12%.

Return on Equity (ROE)	16.68%
Return on Assets (ROA)	8.08%
Return on Capital (ROIC)	10.12%
Revenue Per Employee	297,362
Profits Per Employee	35,128
Employee Count	46
Asset Turnover	1.05
Inventory Turnover	6.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.16% in the last 52 weeks. The beta is 0.82, so Biohit Oyj's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	+21.16%
50-Day Moving Average	2.35
200-Day Moving Average	2.16
Relative Strength Index (RSI)	48.93
Average Volume (20 Days)	12,391

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biohit Oyj had revenue of EUR 13.98 million and earned 1.65 million in profits. Earnings per share was 0.11.

Revenue	13.98M
Gross Profit	8.56M
Operating Income	1.73M
Pretax Income	1.90M
Net Income	1.65M
EBITDA	1.83M
EBIT	1.73M
Earnings Per Share (EPS)	0.11

Full Income Statement

Balance Sheet

The company has 5.00 million in cash and 700,000 in debt, giving a net cash position of 4.30 million or 0.28 per share.

Cash & Cash Equivalents	5.00M
Total Debt	700,000
Net Cash	4.30M
Net Cash Per Share	0.28
Equity (Book Value)	10.80M
Book Value Per Share	0.71
Working Capital	9.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -198,000 and capital expenditures -348,000, giving a free cash flow of -546,000.

Operating Cash Flow	-198,000
Capital Expenditures	-348,000
Free Cash Flow	-546,000
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross margin is 61.28%, with operating and profit margins of 12.34% and 11.81%.

Gross Margin	61.28%
Operating Margin	12.34%
Pretax Margin	13.56%
Profit Margin	11.81%
EBITDA Margin	13.12%
EBIT Margin	12.34%
FCF Margin	n/a

Dividends & Yields

Biohit Oyj does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.51%
Shareholder Yield	-0.51%
Earnings Yield	4.77%
FCF Yield	-1.57%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biohit Oyj has an Altman Z-Score of 7.94.

Altman Z-Score	7.94
Piotroski F-Score	n/a